Call for Abstract

5th European Immunology Conference , will be organized around the theme “Disseminating the New Trends in Immunology”

Euro Immunology 2016 is comprised of 31 tracks and 175 sessions designed to offer comprehensive sessions that address current issues in Euro Immunology 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

The study of the molecular and cellular components that comprise the immune system, including their function and interaction, is the central science of immunology.     
The immune system has been divided into a more primitive innate immune system and,in vertebrates, an acquired or adaptive immune system

The field concerning the interactions among cells and molecules of the immune system, and how such interactions contribute to therecognition and elimination of pathogens. Humans (and vertebrates in general) possess a range of nonspecific mechanical and biochemicaldefenses against routinely encountered bacteria, parasites, viruses, and fungi.The skin, for example, is an effective physical barrier toinfection. Basic chemical defenses are also present in blood, saliva, and tears, and on mucous membranes.
True protection stems from thehost's ability to mount responses targeted to specific organisms, and to retain a form of “memory” 
that results in a rapid, efficient response toa given organism upon a repeat encounter. This more formal sense of immunity, termed 
adaptive immunity, depends upon the coordinatedactivities of cells and molecules of the immune system.

  • Track 1-1B-cell and T-cell receptors
  • Track 1-2Extracellular acidosis
  • Track 1-3Advances in cellular immunology
  • Track 1-4Pattern recognition receptors and cellular encapsulation
  • Track 1-5Cellular senescence and cancer in aging
  • Track 1-6Vaccination-induced cellular immunity
  • Track 1-7Cellular automata and agent based models
  • Track 1-8Cellular antioxidant activities

Nutritional immunology is an emerging discipline that evolved with the study of the detrimental effect of malnutrition on the immune system. The clinical and public health importance of nutritional immunology is also receiving attention. Immune system dysfunctions that result from malnutrition are, in fact, Nutritionally Acquired Immune Deficiency Syndromes (NAIDS). NAIDS afflicts millions of people in the Third World, as well as thousands in modern centers, i.e., patients with cachexia secondary to serious disease, neoplasia or trauma. The human immune system functions to protect the body against foreign pathogens and thereby preventing infection and disease. Optimal functioning of the immune system, both innate and adaptive immunity, is strongly influenced by an individual’s nutritional status, with malnutrition being the most common cause of immunodeficiency in the world. Nutrient deficiencies result in immunosuppression and dysregulation of the immune response including impairment of phagocyte function and cytokine production, as well as adversely affecting aspects of humoral and cell-mediated immunity. Such alterations in immune function and the resulting inflammation are not only associated with infection, but also with the development of chronic diseases including cancer, autoimmune disease, osteoporosis, disorders of the endocrine system and cardiovascular disease.

Rheumatology represents a subspecialty in internal medicine and pediatrics, which is devoted to adequate diagnosis and therapy of rheumatic diseases (including clinical problems in joints, soft tissues, heritable connective tissue disorders, vasculitis and autoimmune diseases). This field is multidisciplinary in nature, which means it relies on close relationships with other medical specialties.The specialty of rheumatology has undergone a myriad of noteworthy advances in recent years, especially if we consider the development of state-of-the-art biological drugs with novel targets, made possible by rapid advances in the basic science of musculoskeletal diseases and improved imaging techniques.

  • Track 3-1Degenerative arthropathies
  • Track 3-2Inflammatory arthropathies
  • Track 3-3Systemic conditions and connective tissue diseases
  • Track 3-4Soft Tissue Rheumatism

Immunoinformatics is a branch of bioinformatics dealing with in silico analysis and modelling of immunological data and problems Immunoinformatics includes the study and design of algorithms for mapping potential B- and T-cell epitopes, which lessens the time and cost required for laboratory analysis of pathogen gene products. Using this information, an immunologist can explore the potential binding sites, which, in turn, leads to the development of new vaccines. This methodology is termed ‘reverse vaccinology’ and it analyses the pathogen genome to identify potential antigenic proteins.5 This is advantageous because conventional methods need to cultivate pathogen and then extract its antigenic proteins. Although pathogens grow fast, extraction of their proteins and then testing of those proteins on a large scale is expensive and time consuming. Immunoinformatics is capable of identifying virulence genes and surface-associated proteins.

  • Track 4-1Immune epitope predictions
  • Track 4-2Immunological omics data analysis
  • Track 4-3Literature mining and immunology
  • Track 4-4Vaccine informatics
  • Track 4-5Immunological data intergration

Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. Immunology deals with physiological functioning of the immune system in states of both health and disease as well as malfunctions of the immune system in immunological disorders like allergies, hypersensitivities, immune deficiency, transplant rejection and autoimmune disorders.

  • Track 5-1Advanced technology for immunology
  • Track 5-2DNA probe technology
  • Track 5-3Antigen arrays in T-cell immunology
  • Track 5-4Automated high-throughput assay
  • Track 5-5Live cell and single molecule imaging experiments
  • Track 5-6Spectral flow cytometer
  • Track 5-7Hybridoma technologies
  • Track 5-8Hybridoma technologies
  • Track 5-9Novel cell analyzer

Diagnostic Immunology. Immunoassays are laboratory techniques based on the detection of antibody production in response to foreign antigens. Antibodies, part of the humoral immune response, are involved in pathogen detection and neutralization.

Diagnostic immunology has considerably advanced due to the development of automated methods.New technology takes into account saving samples, reagents, and reducing cost.The future of diagnostic immunology faces challenges in the vaccination field for protection against HIV and as anti-cancer therapy. Modern immunology relies heavily on the use of antibodies as highly specific laboratory reagents. The diagnosis of infectious diseases, the successful outcome of transfusions and transplantations, and the availability of biochemical and hematologic assays with extraordinary specificity and sensitivity capabilities all attest to the value of antibody detection.Immunologic methods are used in the treatment and prevention of infectious diseases and in the large number of immune-mediated diseases. Advances in diagnostic immunology are largely driven by instrumentation, automation, and the implementation of less complex and more standardized procedures.

Examples of such processes are as follows:

  • miniaturization (use of microtiter plates to save samples and reagents),
  • amplified  immunoassays (chemiluminesent ELISA),
  • flow cytometry with monoclonal antibodies,
  • Immunoglobulins,
  • Molecular methods (polymerase chain reactions).

These methods have facilitated the performance of tests and have greatly expanded the information that can be developed by a clinical laboratory. The tests are now used for clinical diagnosis and the monitoring of therapies and patient responses. Immunology is a relatively young science and there is still so much to discover. Immunologists work in many different disease areas today that include allergy, autoimmunity, immunodeficiency, transplantation, and cancer.

  • Track 6-1Advanced diagnostic tools
  • Track 6-2Diagnostic biomarkers
  • Track 6-3Diagnostic and therapeutic role of micro RNA in immunediseases
  • Track 6-4Diagnostic immunology of HIV-1 virus

Costimulatory molecules can be categorized based either on their functional attributes or on their structure. The costimulatory molecules discussed in this review will be divided into (1) positive costimulatory pathways: promoting T cell activation, survival and/or differentiation; (2) negative costimulatory pathways:antagonizing TCR signalling and suppressing T cell activation; (3) as third group we will discuss the members of the TIM family, a rather “new” family of cell surface molecules involved in the regulation of T cell differentiation and Treg function. Costimulatory pathways have a critical role in the regulation of alloreactivity.  A complex network of positive and negative pathways regulates T cell responses.  Blocking costimulation improves allograft survival in rodents and non-human primates. The costimulation blocker belatacept is being developed as immunosuppressive drug in renal transplantation.

  • Track 7-1T-cell costimulation
  • Track 7-2T-cell costimulation
  • Track 7-3CD27,CD70, CD40, CD40L costimmulatory pathways
  • Track 7-4PD1, PD -L1 pathway
  • Track 7-5Co-inhibitory pathways
  • Track 7-6Novel costimulatory pathways

Reproductive immunology refers to a field of medicine that studies interactions (or the absence of them) between the immune system and components related to the reproductive system, such as maternal immune tolerance towards the fetus, or immunological interactions across the blood-testis barrier. The immune system refers to all parts of the body that work to defend it against harmful enemies. In people with immunological fertility problems their body identifies part of reproductive function as an enemy and sends Natural Killer (NK) cells to attack. A healthy immune response would only identify an enemy correctly and attack only foreign invaders such as a virus, parasite, bacteria, ect.

The concept of reproductive immunology is not widely accepted by all physicians. Those patients who have had repeated miscarriages and multiple failed IVF's find themselves exploring it's possibilities as the reason. With an increased amount of success among treating any potential immunological factors, the idea of reproductive immunology can no longer be overlooked.The failure to conceive is often due to immunologic problems that can lead to very early rejection of the embryo, often before the pregnancy can be detected by even the most sensitive tests. Women can often produce perfectly healthy embryos that are lost through repeated "mini miscarriages." This most commonly occurs in women who have conditions such as endometriosis, an under-active thyroid gland or in cases of so called "unexplained infertility." It has been estimated that an immune factor may be involved in up to 20% of couples with otherwise unexplained infertility. These are all conditions where abnormalities of the woman’s immune system may play an important role.

  • Track 8-1Current trends in reproductive immunology
  • Track 8-2Invitro fertilization reproductive immunology
  • Track 8-3Clinical practices in reproductive immunology
  • Track 8-4Avian reproductive immune system
  • Track 8-5Autoimmune diseases and reproductive immunology
  • Track 8-6Procine reproductive and respiratory syndrome

Neuroimmunology, a branch of immunology that deals especially with the interrelationships of the nervous system and immune responses andautoimmune disorders. Its deals with particularly fundamental and applied neurobiology,neurology,neuropathology,neurochemistry,Neurovirology,neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays).

  • Track 9-1Neuro-immune algorithm
  • Track 9-2Neural stem cell transplantation
  • Track 9-3Neuro immuno endocrine system
  • Track 9-4Interferon signaling and neuro immunology
  • Track 9-5Experimental neuro immunology

T cell: A type of white blood cell that is of key importance to the immune system and is at the core of adaptive immunity, the system that tailors the body's immune response to specific pathogens. The T cells are like soldiers who search out and destroy the targeted invaders. Immature T cells (termed T-stem cells) migrate to the thymus gland in the neck, where they mature and differentiate into various types of mature T cells and become active in the immune system in response to a hormone called thymosin and other factors. T-cells that are potentially activated against the body's own tissues are normally killed or changed ("down-regulated") during this maturational process.There are several different types of mature T cells. Not all of their functions are known. T cells can produce substances called cytokines such as the interleukins which further stimulate the immune response. T-cell activation is measured as a way to assess the health of patients with HIV/AIDS and less frequently in other disorders. T cell are also known as T lymphocytes. The "T" stands for "thymus" -- the organ in which these cells mature. As opposed to B cells which mature in the bone marrow. B cells, also known as B lymphocytes, are a type of white blood cell of the lymphocyte subtype. They function in the humoral immunity component of the adaptive immune system by secreting antibodies. Many B cells mature into what are called plasma cells that produce antibodies (proteins) necessary to fight off infections while other B cells mature into memory B cells. All of the plasma cells descended from a single B cell produce the same antibody which is directed against the antigen that stimulated it to mature. The same principle holds with memory B cells. Thus, all of the plasma cells and memory cells "remember" the stimulus that led to their formation. The maturation of B cells takes place in birds in an organ called the bursa of Fabricus. B cells in mammals mature largely in the bone marrow. The B cell, or B lymphocyte, is thus an immunologically important cell. It is not thymus-dependent, has a short lifespan, and is responsible for the production of immunoglobulins. It expresses immunoglobulins on its surface.

  • Track 10-1T-cell derived B-cell growth factor
  • Track 10-2T cell-B cell collaboration
  • Track 10-3Invitro invivo studies
  • Track 10-4Cell culture models for t-cell mediated b-cell activation
  • Track 10-5B and T cell homeostasis
  • Track 10-6T-cells and B-cells in multiple sclerosis
  • Track 10-7T-cells and B-cells in multiple sclerosis

 Although medications available for allergy are usually very effective, they do not cure people of allergies. Allergen immunotherapy is the closest thing we have for a "cure" for allergy, reducing the severity of symptoms and the need for medication for many allergy sufferers. Allergen immunotherapy involves the regular administration of gradually increasing doses of allergen extracts over a period of years. Immunotherapy can be given to patients as an injection or as drops or tablets under the tongue (sublingual).Allergen immunotherapy changes the way the immune system reacts to allergens, by switching off allergy. The end result is that you become immune to the allergens, so that you can tolerate them with fewer or no symptoms. Allergen immunotherapy is not, however, a quick fix form of treatment. Those agreeing to allergen immunotherapy need to be committed to 3-5 years of treatment for it to work, and to cooperate with your doctor to minimize the frequency of side effects. Allergen immunotherapy is usually recommended for the treatment of potentially life threatening allergic reactions to stinging insects. Published data on allergen immunotherapy injections shows that venom immunotherapy can reduce the risk of a severe reaction in adults from around 60 % per sting, down to less than 10%. In Australia and New Zealand, venom immunotherapy is currently available for bee and wasp allergy. Jack Jumper Ant immunotherapy is available in Tasmania for Tasmanian residents. Allergen immunotherapy is often recommended for treatment of allergic rhinitis

  • Track 11-1Hypersensitivity, asthma & allergic responses
  • Track 11-2Mast cell in allergic inflations
  • Track 11-3Allergy immunotherapy
  • Track 11-4Allergic disease models
  • Track 11-5Advances in allergy research
  • Track 11-6 Food allergy

Autoimmunity is the system of  immune responses of an organism against its own cells and tissues. Any disease that results from such an aberrant immune response is termed an autoimmune disease.

Autoimmunity is present to some extent in everyone and is usually harmless. However, autoimmunity can cause a broad range of human illnesses, known collectively as autoimmune diseases. Autoimmune diseases occur when there is progression from benign autoimmunity to pathogenic autoimmunity. This progression is determined by genetic influences as well as environmental triggers. Autoimmunity is evidenced by the presence of autoantibodies (antibodies directed against the person who produced them) and T cells that are reactive with host antigens.

Current treatments for allergic and autoimmune disease treat disease symptoms or depend on non-specific immune suppression. Treatment would be improved greatly by targeting the fundamental cause of the disease, that is the loss of tolerance to an otherwise innocuous antigen in allergy or self-antigen in autoimmune disease (AID). Much has been learned about the mechanisms of peripheral tolerance in recent years. We now appreciate that antigen presenting cells (APC) may be either immunogenic or tolerogenic, depending on their location, environmental cues and activation state

  • Track 12-1Mutine autoimmune arthritis
  • Track 12-2 Autoimmune myasthenia gravis
  • Track 12-3Inflammatory arthritis
  • Track 12-4Tissue regeneration in autoimmunity
  • Track 12-5Advances in autoimmunity

Autoimmunity is the system of immune responses of an organism against its own cells and tissues. Any disease that results from such an aberrant immune response is termed an autoimmune disease.

Autoimmunity is present to some extent in everyone and is usually harmless. However, autoimmunity can cause a broad range of human illnesses, known collectively as autoimmune diseases. Autoimmune diseases occur when there is progression from benign autoimmunity to pathogenic autoimmunity. This progression is determined by genetic influences as well as environmental triggers. Autoimmunity is evidenced by the presence of autoantibodies (antibodies directed against the person who produced them) and T cells that are reactive with host antigens.

  • Track 13-1Autoantibodies , Auto-antigens and vaccine antigens in plant cells
  • Track 13-2Nucleic acid associated autoantigens
  • Track 13-3Intracellular autoantigens
  • Track 13-4Tumor antigens & recombinant autoantigens
  • Track 13-5Autoantibody explosion
  • Track 13-6Cellular & retinal auto antigens
  • Track 13-7Auto-antibodies in cancer patients
  • Track 13-8Factor-h autoantibody assay
  • Track 13-9Immunoglobulin g a & serum autoantibodies

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans. Some infectious diseases can be passed from person to person. Some are transmitted by bites from insects or animals. And others are acquired by ingesting contaminated food or water or being exposed to organisms in the environment.Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild complaints may respond to rest and home remedies, while some life-threatening infections may require hospitalization.

Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines. Frequent and thorough hand-washing also helps protect you from infectious diseases

There are four main kinds of germs:

  • Bacteria - one-celled germs that multiply quickly and may release chemicals which can make you sick
  • Viruses - capsules that contain genetic material, and use your own cells to multiply
  • Fungi - primitive plants, like mushrooms or mildew
  • Protozoa - one-celled animals that use other living things for food and a place to live
  • Track 14-1Influenza virus and immune system
  • Track 14-2HIV & AIDS
  • Track 14-3Viral infections
  • Track 14-4Bacterial infections
  • Track 14-5Viral-bacterial confection
  • Track 14-6Inflammatory infectious diseases
  • Track 14-7Infectious diseases and immune system regulation

Immunotherapy, also called biologic therapy, is a type of cancer treatment designed to boost the body's natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function.Immunotherapy is treatment that uses certain parts of a person’s immune system to fight diseases such as cancer. This can be done in a couple of ways:1)Stimulating your own immune system to work harder or smarter to attack cancer cells2)Giving you immune system components, such as man-made immune system proteinsSome types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future. Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

  • Track 15-1Dermatophagoides pteronyssinus and immunotherapy
  • Track 15-2Efficacy and safety in immunotherapy
  • Track 15-3Sublingual immunotherapy
  • Track 15-4Cancer immunotherapy

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. There are two basic types of vaccines: live attenuated and inactivated. The characteristics of live and inactivated vaccines are different, and these characteristics determine how the vaccine is used. Live attenuated vaccines are produced by modifying a disease-producing (“wild”) virus or bacteria in a laboratory.

  • Track 16-1Bacterial vaccines
  • Track 16-2Viral vaccines
  • Track 16-3Parasite vaccines
  • Track 16-4Cancer vaccines
  • Track 16-5Cancer vaccines
  • Track 16-6Autoimmune disease vaccines
  • Track 16-7Allergy vaccines
  • Track 16-8Vaccine safety and regulation
  • Track 16-9Immune system and vaccination
  • Track 16-10Infectious diseases & vaccines; anthrax, small pox, hepatitis
  • Track 16-11Vaccine delivery strategies and safety
  • Track 16-12Vectors for vaccine delivery
  • Track 16-13Types of vaccines

The tumour is an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system are a fundamental component of the tumour microenvironment. Importantly, therapeutic strategies can harness the immune system to specifically target tumour cells and this is particularly appealing owing to the possibility of inducing tumour-specific immunological memory, which might cause long-lasting regression and prevent relapse in cancer patients. The composition and characteristics of the tumour microenvironment vary widely and are important in determining the anti-tumour immune response. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer

  • Track 17-1Neutrophils and macrophages in cancer/tumor
  • Track 17-2Immune markers in cancer and tumor
  • Track 17-3Anti-cancer/tumor immunity
  • Track 17-4Tumor angiogenesis
  • Track 17-5Engineered mouse models in cancer
  • Track 17-6Advanced technology in cancer/tumor immunology
  • Track 17-7Cancer therapy and clinical cancer research

Autoimmune diseases can affect almost any part of the body, including the heart, brain, nerves, muscles, skin, eyes, joints, lungs, kidneys, glands, the digestive tract, and blood vessels.

The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain, and swelling. How an autoimmune disease affects you depends on what part of the body is targeted. If the disease affects the joints, as in rheumatoid arthritis, you might have joint pain, stiffness, and loss of function. If it affects the thyroid, as in Graves’ disease and thyroiditis, it might cause tiredness, weight gain, and muscle aches. If it attacks the skin, as it does in scleroderma/systemic sclerosis, vitiligo, and systemic lupus erythematosus (SLE), it can cause rashes, blisters, and color changes.Many autoimmune diseases don’t restrict themselves to one part of the body. For example, SLE can affect the skin, joints, kidneys, heart, nerves, blood vessels, and more. Type 1 diabetes can affect your glands, eyes, kidneys, muscles, and more.

  • Track 18-1Autoimmune diseases: Organ and tissue
  • Track 18-2Inflammatory bowel disease
  • Track 18-3Major histocompatibility complex classes
  • Track 18-4Gastro intestinal autoimmunity, skin and autoimmunity
  • Track 18-5Systemic lupus erythematosus
  • Track 18-6Infection and autoimmunity, and metabolic disorders
  • Track 18-7Multiple sclerosis, and mislenious autoimmune diseases
  • Track 18-8Predisposing factors for autoimmunity
  • Track 18-9Autoimmune disease in animal models
  • Track 18-10Therapies for human autoimmune disease

Clinical Immunology has evolved over the past two decades from a predominant laboratory base to a combined clinical and laboratory specialty. The clinical work of Immunologists is largely out-patient based and involves primary immunodeficiency, allergy, autoimmune rheumatic disease and systemic vasculitis (jointly with Rheumatologists), joint pediatric clinics for children with immunodeficiency and allergy and immunoglobulin infusion clinics for patients with antibody deficiency. On the laboratory front, Consultant Immunologists are responsible for directing diagnostic immunology services and perform a wide range of duties including clinical liaison, interpretation and validation of results, quality assurance and assay development.

  • Track 19-1Advances clinical immunology
  • Track 19-2Mechanisms in clinical immunology
  • Track 19-3Allergy & clinical immunology
  • Track 19-4Endotypes & phenotypes in chronic rhinosinusitis
  • Track 19-5Immunological clinical trials
  • Track 19-6Oral immunotherapy
  • Track 19-7Clinical manifestation and IgE recognition
  • Track 19-8Clinical outcomes in hematopopoietic stem cell transplantation

Antigen processing is an immunological process that prepares antigens for presentation to special cells of the immune system called T lymphocytes. It is considered to be a stage of antigen presentation pathways. The process by which antigen-presenting cells digest proteins from inside or outside the cell and display the resulting antigenic peptide fragments on cell surface MHC molecules for recognition by T cells is central to the body's ability to detect signs of infection or abnormal cell growth. As such, understanding the processes and mechanisms of antigen processing and presentation provides us with crucial insights necessary for the design of vaccines and therapeutic strategies to bolster T-cell responses.

  • Track 20-1Advanced research in antigen sampling & processing
  • Track 20-2Circulatory antigen processing
  • Track 20-3Viral interferences
  • Track 20-4Tap independent processing pathways
  • Track 20-5Humoral and cellular immune responses
  • Track 20-6Antigen processing through macroautophagy

Cell adhesion, it is the process by which cells interact and attach to a surface, substrate or another cell. Cell adhesion is essential for cell migration and tissue integrity. This process not only promotes the proper functioning of individual cells, but it also allows communication and coordination among groups of cells — including the cells that make up organized communities called tissues. Cell adhesion occurs from the action of Trans membrane glycoproteins called cell adhesion molecules,examples of this adhesion include integrins, syndecans, selectins and cadherins.

  • Track 21-1Chemokine and chemo attractants
  • Track 21-2Adhesion molecules in cellular migration
  • Track 21-3Leukocyte extravation

Haematopoiesis is the synthesis and development of Blood cells. Occurs during embryonic development and throughout adulthood to produce and replenish the blood system. Cellular blood components are derived from haematopoietic stem cells that reside mainly in the bone marrow, a major site of adult haematopoiesis. The blood system contains more than 10 different blood cell types with various functions: Leukocytes represent many specialized cell types involved in innate and acquired immunity. Erythrocytes provide O2 and CO2 transport, whereas megakaryocytes generate platelets for blood clotting and wound healing.

Immune System Development:

Our immune system defends people against germs and microorganisms. The immune system consists of lymphoid organs that can be divided into the primary and secondary immune systems as well as the myeloid and lymphoid cells, these arise via haematopoiesis. The primary lymphoid organs are the bone marrow and thymus. These are the sites at which haematopoiesis occurs and immature lymphocytes grow, develop, and differentiate. The secondary, or peripheral, lymphoid organs primarily consist of the spleen and lymph nodes and play roles in antigen presentation and adaptive immune response initiation.

  • Track 22-1Hematopoietic stem cells
  • Track 22-2Myeloid and erythroid cells
  • Track 22-3Lymphoid organs development

The effective immune response is an outcome of the reaction between antigen and a network of immunologically competent cells. The immune response is controlled by various mechanisms which restore the immune system to a resting state when response to a given antigen is no longer required. Effective immune responses are usually resulted from the interactions between pathogens and a network of immunologic elements.

  • Track 23-1Cell signalling & their role in immunity
  • Track 23-2MHC & its role in immunity
  • Track 23-3Transcriptional & post transcriptional regulations of the immune system
  • Track 23-4Innate immunity & the complement system

The immune system is the collection of cells, tissues and molecules that protects the body from numerous pathogenic microbes and toxins in our environment. This defense against microbes has been divided into two general types of reactions: reactions of innate immunity and reactions of adaptive immunity. Thus, innate and adaptive immunity can be thought of as two equally important aspects of the immune system. As you will see, each aspect differs with respect to how quickly it responds and for how long it responds to pathogens, its central effector cell types and its specificity for different classes of microbes. As its name suggests, the innate immune system consists of cells and proteins that are always present and ready to mobilize and fight microbes at the site of infection. It thus provides an immediate response to foreign invader.The main components of the innate immune system are 1) physical epithelial barriers, 2) phagocytic leukocytes, 3) dendritic cells, 4) a special type of lymphocyte called a natural killer (NK) cell, and 5) circulating plasma proteins. Innate immune responses are not specific to a particular pathogen in the way that the adaptive immune responses are. They depend on a group of proteins and phagocytic cells that recognize conserved features of pathogens and become quickly activated to help destroy invaders.

  • Track 24-1Inflammasome & innate immunity
  • Track 24-2Molecular Mechanisms of Innate Immune System
  • Track 24-3Fc-fusion proteins & receptors
  • Track 24-4Acute phase proteins

Pathology is a branch of medical science primarily concerning the examination of organs, tissues, and bodily fluids in order to make a diagnosis of disease. Immunopathology is a branch of biomedical science concerned with immune responses to disease, with immunodeficiency diseases, and with diseases caused by immune mechanisms.  It includes the study of the pathology of an organismorgan system, or disease with respect to the immune system, immunity, and immune responses. The immune pathological reaction is caused by release of toxins and the apoptosis of infected cell.

  • Track 25-1Cardiac immunopathology
  • Track 25-2Neurological immunopathology
  • Track 25-3Respiratory immunopathology
  • Track 25-4Infection site; release of endotoxins, cytokines

The mucosal surfaces of the body have a higher risk of infection due to their synergy with the external environment. Mucosal immunology brings up those aspects of the immune system that protect the body from infection. It provides three main functions: protects the mucous membrane against infection, preventing the uptake of antigens, microorganisms, and other foreign materials, and moderating the organism's immune response to that material. The mucosal immune system is comprised of mechanical (mucus), chemical and cellular factors. 

  • Track 26-1Immune responses at mucosal surface
  • Track 26-2Mucosal associated lymphoid tissue
  • Track 26-3Mucosal tolerance and disease
  • Track 26-4Roles & regulations of IgA

Transplantation can be a influential method for the treatment of end-stage organ failure. Transplantation is the process of transferring cells, tissues, or organs from one site to another. The dysfunction of an organ system can be reformed with transplantation of an organ from a donor. However, the immune system remains the most dreadful barrier to transplantation as a routine medical treatment. The immune system has developed complex and effective mechanisms to conflict foreign agents. These mechanisms are also involved in the dismissal of transplanted organs, which are perceived as foreign by the recipient's immune system.

  • Track 27-1Graft vs Host Disease
  • Track 27-2Graft rejection
  • Track 27-3Transplantation tolerance
  • Track 27-4Solid organs transplantation
  • Track 27-5Cellular or bone marrow transplantation

Viruses are strongly immunogenic and produce 2 types of immune responses; humoral and cellular. T and B cells do not generally recognize the same epitopes present on the same virus. B cells see the free unaltered proteins in their native 3-D conformation whereas T cells usually see the Ag in a denatured form in conjunction with MHC molecules. The characteristics of the immune reaction to the same virus may differ in different individuals depending on their genetic constitutions.

  • Track 28-1Immune response to viral pathogens
  • Track 28-2Pathogenesis of viral infection
  • Track 28-3Innate immunity against viral pathogens
  • Track 28-4Viral invasion, evasion, and resistance
  • Track 28-5Viral evasion proteins

Immunodeficiency is a state in which the immune system's ability to fight infectious disease is compromised or entirely absent. Immunodeficiency disorders prevent your body from adequately fighting infections and diseases. An immunodeficiency disorder also makes it easier for you to catch viruses and bacterial infections in the first place. Immunodeficiency disorders are often categorized as either congenital or acquired. A congenital, or primary, disorder is one you were born with. Acquired, or secondary, disorders are disorders you get later in life. Acquired disorders are more common than congenital disorders. Immune system includes the following organs: spleen, tonsils, bone marrow, lymph nodes. These organs make and release lymphocytes. Lymphocytes are white blood cells classified as B cells and T cells. B and T cells fight invaders called antigens. B cells release antibodies specific to the disease your body detects. T cells kill off cells that are under attack by disease. An immunodeficiency disorder disrupts your body’s ability to defend itself against these antigens. Types of immunodeficiency disorder are Primary immunodeficiency disorders & Secondary  immunodeficiency  disorders.

Primary immunodeficiency disorders are immune disorders you are born with. Primary disorders include:

X-linked agammaglobulinemia (XLA)

·         Common variable immunodeficiency (CVID)

·         Severe combined immunodeficiency (SCID)

Secondary disorders happen when an outside source, such as a toxic chemical or infection, attacks your body. Severe burns and radiation also can cause secondary disorders.

Secondary disorders include: AIDS, cancers of the immune system  such as leukemia, immune-complex diseases such as viral hepatitis, multiple myeloma.

  • Track 29-1Congenital/Acquired immunodeficiency
  • Track 29-2Immune system and primary/secondary immunodeficiences
  • Track 29-3T cell and B cell immunodeficiency
  • Track 29-4Severe combined immunodeficiency
  • Track 29-5MHC deficiencies

Pathogenesis describes the process by which an infection leads to disease. Cells of the immune system recognize and abolish pathogenic organisms and derived toxins. Immunity is provided by cells of the innate and adaptive arms of the immune system. Pathogenesis includes microbial infection, inflammation, malignancy and tissue breakdown.

  • Track 30-1Immunity & pathogenesis
  • Track 30-2Haemorrhagic fevers and pathophysiology
  • Track 30-3Super antigens: staphylococcus and streptococcus
  • Track 30-4Macrophages; the hosts
  • Track 30-5Sepsis & its pathophysiology
  • Track 30-6Lymphocyte apoptosis

Microbial Immunology expects studies examining responses to any microbial agent, including viruses, bacteria and parasites. The Microbiology, Microbial Pathogenesis and Immunology concentrates on the study of host-pathogen interactions at the molecular and cellular levels

Most parasites, by the nature of their continuous contact with the immune system, generate a prolific immune response. Unfortunately, much of this response is not protective, and some is harmful. Protective immunity in some infections is due to a combination of humoral and cellular immunity; in this circumstance parasites are coated with antibody which makes them susceptible to direct cytotoxicity by macrophages, eosinophils, and neutrophils. Antibody alone is protective against some other infections. Nonspecific and genetic factors are clearly important but are still undefined participants in the host response. The immune response may be pathogenic by inducing hypersensitivity, immunologically mediated fibrosis, or circulating immune complexes. Additionally, Parasites have evolved unique ways of protecting themselves from the immune system, including altering their antigenic coat and inducing immunosuppression. Attempts to isolate "host-protective" antigens in parasitic infections may lead to effective vaccine development

  • Track 31-1Pathogenicity of bacterial, fungal, parasitic infections
  • Track 31-2Innate immunity against bacteria
  • Track 31-3Innate immunity against parasities and fungi